Carboplatin plus paclitaxel as first-line therapy for locally advanced recurrent metastatic endometrial cancer.
2010
e15553 Background: To evaluate the efficacy and safety of carboplatin plus paclitaxel in patients with advanced loco regional, recurrent and metastatic endometrial cancer. Methods: Thirty two eligi...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI